Prognosis – HAEMA

Post ASH 2022: High-grade B-cell Lymphomas, what’s new?

Posted on October 16, 2024October 16, 2024 by admin

Review Article

Haema 2023; 14(1-4):34-38

Pineopi Vryttia, Sotirios G. Papageorgiou

Second Department of Internal Medicine and Research Institute, Hematology Unit, Attikon University General Hospital

Continue reading “Post ASH 2022: High-grade B-cell Lymphomas, what’s new?” →

Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies

Posted on November 2, 2022April 3, 2023 by admin

Review Article

Haema 2022; 13(1-2):14-19

Athanasios Liaskas¹, Fotios Panitsas¹, Evrydiki Kravvariti², Maria K. Angelopoulou¹, Gerassimos A. Pangalis³, Theodoros P. Vassilakopoulos¹

¹Department of Haematology,
²First Department of Propaedeutic Internal Medicine, Joint Rheumatology Academic Program,
³Department of Haematology, Athens Medical Center, Psychikon Branch, Athens,Greece

Continue reading “Very Late Relapses in Hodgkin Lymphoma: A Critical Comparison of Major Published Studies” →